Wave Life Sciences Ltd (WVE): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 17 US Dollar | 17 | 2 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 197.228.968 | 13,24 | 6,51 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Wave Life Sciences Ltd
Mitarbeiter 317
Handelsplatz NASDAQ
Ticker Symbol WVE
IPO Datum 2015-11-11
Adresse 733 Concord Avenue, Cambridge, MA, United States, 02138
Webseite https://wavelifesciences.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Paul B. Bolno M.B.A., M.D. | President, CEO & Director |
| 2 | Dr. Gregory L. Verdine Ph.D. | Founder & Director |
| 3 | Mr. Kyle B. Moran CFA | CFO & Principal Accounting Officer |
| 4 | Dr. Chandra Vargeese Ph.D. | Chief Technology Officer |
| 5 | Dr. Erik Ingelsson M.D., Ph.D. | Chief Scientific Officer |
| 6 | Ms. Kate Rausch | Vic President of Corporate Affairs & Investor Relations |
| 7 | Ms. Linda Rockett J.D. | Senior VP & General Counsel |
| 8 | Katie Sullivan | Senior Director of Corporate Communications |
| 9 | Ms. Daryn Lewis | Senior VP & Head of Human Resources |
| 10 | Dr. Sridhar Vaddeboina M.B.A., Ph.D. | Senior Vice President of Chemistry, Manufacturing & Controls |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RA Capital Management, LLC | 13,69% | 98,28 Mio. USD |
| 2 | BlackRock Inc | 9,75% | 69,96 Mio. USD |
| 3 | GSK PLC | 9,26% | 66,48 Mio. USD |
| 4 | Maverick Capital Ltd | 5,22% | 37,45 Mio. USD |
| 5 | Driehaus Capital Management LLC | 2,76% | 19,83 Mio. USD |
| 6 | PRIMECAP Management Company | 2,72% | 19,51 Mio. USD |
| 7 | FMR Inc | 2,50% | 17,93 Mio. USD |
| 8 | 683 Capital Management LLC | 2,49% | 17,85 Mio. USD |
| 9 | State Street Corp | 2,46% | 17,63 Mio. USD |
| 10 | Readystate Asset Management LP | 2,40% | 17,22 Mio. USD |
| 11 | M28 Capital Management LP | 2,33% | 16,72 Mio. USD |
| 12 | Geode Capital Management, LLC | 1,96% | 14,10 Mio. USD |
| 13 | Two Sigma Investments LLC | 1,88% | 13,51 Mio. USD |
| 14 | Algert Global LLC | 1,43% | 10,27 Mio. USD |
| 15 | Qube Research & Technologies | 1,41% | 10,11 Mio. USD |
| 16 | Squarepoint Ops LLC | 1,29% | 9,26 Mio. USD |
| 17 | Morgan Stanley - Brokerage Accounts | 1,23% | 8,83 Mio. USD |
| 18 | Vanguard Portfolio Management, LLC | 1,07% | 7,69 Mio. USD |
| 19 | Pfizer Inc | 0,95% | 6,83 Mio. USD |
| 20 | Millennium Management LLC | 0,92% | 6,60 Mio. USD |